PTPRC and breast cancer: In CD45-depleted blood (CD45-DB) fractions, the downregulated miR-205-5p was found in samples expressing epithelial and/or mesenchymal markers (CTC+) that could contribute to reduced susceptibility and increased survival of hematogenously disseminated BC cells mediated by increased expression of several target genes including ZEB1.